Anti-adipogenic effects of N-acetyltyramine from termite-associated Streptomyces sp. M45

Se Yun Jeong1, Mei Tong He2, Mihyang Kim3

  • 1School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea. khkim83@skku.edu.

PubMed

Insights

Novel compounds from termite-associated bacteria show potential for obesity treatment. N-acetyltyramine inhibited fat cell differentiation and key gene expression, offering a new avenue for anti-obesity drug development.

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Metabolic Disease Research

Background:

  • Obesity is a significant global health concern requiring new therapeutic strategies.
  • Adipogenesis, the process of fat cell formation, is a key target for anti-obesity interventions.
  • Microbial metabolites represent a promising source of novel bioactive compounds.

Purpose of the Study:

  • To investigate the anti-adipogenic potential of metabolites isolated from termite-associated *Streptomyces* sp. M45.
  • To identify and characterize small molecules that can modulate fat cell differentiation.
  • To explore the molecular mechanisms underlying the anti-adipogenic effects.

Main Methods:

  • Isolation and structural elucidation of six metabolites (1-6) using NMR spectroscopy and LC-MS.
  • Evaluation of anti-adipogenic activity in differentiated 3T3-L1 cells.
  • Assessment of lipid accumulation and adipogenic transcription factor expression (C/EBPα, C/EBPβ, SREBP2).
  • Mechanistic studies involving gene expression analysis (C/EBPα, SREBP2, FASN, UCP2, leptin).

Main Results:

  • Six metabolites were isolated and structurally characterized, including a corrected structure for 2-acetamido-3-hydroxybenzoic acid (1).
  • *N*-acetyltyramine (2) demonstrated significant inhibition of adipocyte differentiation in 3T3-L1 cells without affecting cell viability.
  • Compound 2 downregulated key adipogenic genes, including C/EBPα, SREBP2, FASN, UCP2, and leptin.

Conclusions:

  • *N*-acetyltyramine (2) is a potent inhibitor of adipogenesis in vitro.
  • This study identifies *N*-acetyltyramine as a potential therapeutic lead for obesity management.
  • The findings highlight the value of exploring microbial natural products for novel anti-obesity agents.

Related Concept Videos